QTREX Quantum COO granted 550,000 RSUs

shabtay abraham reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/15/2026 - 07:00 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

shabtay abraham reported acquisition or exercise transactions in this Form 4 filing.

QTREX Quantum Ltd. granted COO Shabtay Abraham 550,000 equity units recorded as Ordinary Shares at an effective price of $0.0000 per share under the company’s 2019 plan. The grant consists of Restricted Share Units, with 183,334 RSUs vesting on July 1, 2027 and the remaining RSUs vesting quarterly over two years. After this award, he holds 1,882,713 ordinary shares directly.

Insider Trade Summary

Grant/Award: 550,000 shares

Grant/Award 1 txn

Insider shabtay abraham

Role COO

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	550,000	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 1,882,713 shares (Direct)

Footnotes (1)

1. F1. The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event.

Key Figures

RSUs/Ordinary Shares Granted: 550,000 shares Grant Price per Share: $0.0000 Shares Held After Transaction: 1,882,713 shares +1 more

4 metrics

RSUs/Ordinary Shares Granted 550,000 shares Grant/award acquisition to COO Shabtay Abraham on 2026-07-06

Grant Price per Share $0.0000 Effective price for 550,000 granted equity units

Shares Held After Transaction 1,882,713 shares Direct ordinary share holdings following the grant

Initial Vesting Tranche 183,334 RSUs RSUs scheduled to vest on July 1, 2027

Key Terms

Restricted Share Units ("RSUs"), 2019 Plan, Ordinary Shares, vest

4 terms

Restricted Share Units ("RSUs") financial

"The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s 2019 Plan"

2019 Plan financial

"were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan"

Ordinary Shares financial

"security_title": "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

vest financial

"and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did QTEX COO Shabtay Abraham receive in this Form 4 transaction?

COO Shabtay Abraham received a grant of 550,000 equity units reported as Ordinary Shares from QTREX Quantum Ltd. The award represents Restricted Share Units granted under the company’s 2019 plan as part of his compensation package, subject to multi-year vesting conditions.

At what price were the 550,000 QTEX RSUs/Ordinary Shares granted?

The 550,000 units granted to QTEX COO Shabtay Abraham carry an effective grant price of $0.0000 per share. This indicates a compensation-related award rather than an open-market purchase, consistent with equity incentives typically issued under an employee equity compensation plan.

How do the newly granted QTEX RSUs to the COO vest over time?

Of the award to QTEX COO Shabtay Abraham, 183,334 Restricted Share Units will vest on July 1, 2027. The remaining RSUs will then vest on a quarterly basis over the following two years, creating a staggered, time-based vesting schedule tied to continued service.

How many QTEX ordinary shares does Shabtay Abraham hold after this grant?

After the reported grant, Shabtay Abraham holds 1,882,713 QTEX ordinary shares directly. This figure reflects his ownership position immediately following the award of 550,000 equity units and provides context for his overall equity stake in the company.

Was the QTEX insider transaction a market purchase or a compensation grant?

The QTEX insider transaction was a grant/award acquisition, not an open-market purchase. It is coded as an “A” transaction, representing a grant under QTREX Quantum Ltd.’s 2019 Plan, with an effective price of $0.0000 per share and a defined vesting schedule.

Under which plan were the QTEX RSUs granted to the COO?

The RSUs granted to QTEX COO Shabtay Abraham were issued under QTREX Quantum Ltd.’s 2019 Plan. The footnote specifies that these Restricted Share Units are subject to future vesting milestones beginning in 2027 and continuing quarterly for two years thereafter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

shabtay abraham

(Last) (First) (Middle)

2 HA-TIDHAR ST.

(Street)

RA'ANANA 4366504

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
QTREX Quantum Ltd. [ QTEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/06/2026		A		550,000(1)	A	$0	1,882,713	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event.

	/s/ Abraham Shabtay	07/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)